<?xml version="1.0" encoding="UTF-8"?>
<p id="JVEv5-para-0035">Several new viral and host factors were described as potential targets for drug development with a key goal being the inactivation of the covalently closed circular DNA (cccDNA), the vitally important stable HBV transcription template. Advancing the understanding of the cccDNA formation and function is critical to providing the basis for effectively disabling this replication intermediate.</p>
